First trials test targeting of α-synuclein for Parkinson disease

Nat Rev Neurol. 2022 Dec;18(12):703-704. doi: 10.1038/s41582-022-00726-6.
No abstract available

Publication types

  • Comment

MeSH terms

  • Humans
  • Parkinson Disease* / diagnosis
  • alpha-Synuclein*

Substances

  • alpha-Synuclein